Ospexin (Cefalexin)

Cefalexin, the active ingredient in Ospexin, is a first‑generation cephalosporin presented as an oral dosage form for oral use. It treats a range of bacterial infections, particularly in adults and children, by targeting susceptible Gram‑positive and some Gram‑negative organisms.

GNH USA supplies Ospexin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains across multiple regions.

Cefalexin is a first‑generation cephalosporin antibiotic that acts on bacterial infections of several organ systems.

- Skin and soft‑tissue infections: eliminates susceptible bacteria, reducing redness, swelling and pain. - Respiratory tract infections: clears pathogens in conditions such as acute bronchitis and sinusitis, improving breathing and cough. - Urinary tract infections: eradicates causative organisms, relieving dysuria and frequency. - Bone and joint infections: penetrates bone tissue to treat osteomyelitis and septic arthritis caused by susceptible strains.

Cefalexin may cause a variety of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Diarrhoea - Abdominal pain or discomfort - Rash or mild skin irritation - Headache - Altered taste perception

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis - Severe allergic reactions such as anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias including neutropenia or thrombocytopenia - Hepatic enzyme elevations or jaundice - Renal impairment or interstitial nephritis

Before prescribing Ospexin, clinicians should consider several safety factors.

- Renal impairment: adjust dose or monitor renal function closely. - Pregnancy Category B: use only when clearly needed after risk‑benefit assessment. - Known beta‑lactam allergy: avoid in patients with hypersensitivity to penicillins or other cephalosporins. - Concomitant anticoagulant therapy: monitor INR or coagulation parameters. - Prolonged therapy: watch for secondary infections or overgrowth of resistant organisms. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Cefalexin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Probenecid: may raise cefalexin plasma levels, increasing risk of toxicity. - Live bacterial vaccines: concurrent use can diminish vaccine effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: cefalexin may potentiate anticoagulant effect; monitor INR. - Oral contraceptives: possible reduction in hormonal efficacy; consider backup contraception. - Aminoglycosides: combined use may heighten nephrotoxicity; assess renal function regularly.